Genmab A/S (GMAB)
USD 21.48
(2.63%)
USD 21.48
(2.63%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 680 Million DKK | 30.02% |
| 2022 | 523 Million DKK | 44.08% |
| 2021 | 363 Million DKK | 31.05% |
| 2020 | 277 Million DKK | 78.71% |
| 2019 | 155 Million DKK | 0.0% |
| 2018 | - DKK | 0.0% |
| 2017 | - DKK | 0.0% |
| 2016 | - DKK | 0.0% |
| 2015 | - DKK | -100.0% |
| 2014 | 118 Thousand DKK | -66.85% |
| 2013 | 356 Thousand DKK | -81.18% |
| 2012 | 1.89 Million DKK | -68.76% |
| 2011 | 6.05 Million DKK | -48.88% |
| 2010 | 11.84 Million DKK | -33.96% |
| 2009 | 17.93 Million DKK | 100.11% |
| 2008 | 8.96 Million DKK | 9.56% |
| 2007 | 8.18 Million DKK | -27.28% |
| 2006 | 11.25 Million DKK | -22.33% |
| 2005 | 14.48 Million DKK | -30.89% |
| 2004 | 20.96 Million DKK | 12.88% |
| 2003 | 18.56 Million DKK | 74.76% |
| 2002 | 10.62 Million DKK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 918 Million DKK | 0.0% |
| 2024 Q2 | 925 Million DKK | 0.0% |
| 2023 Q2 | 721 Million DKK | -2.57% |
| 2023 Q4 | 680 Million DKK | -4.23% |
| 2023 FY | 680 Million DKK | 30.02% |
| 2023 Q3 | 710 Million DKK | -1.53% |
| 2023 Q1 | 740 Million USD | 41.49% |
| 2022 Q4 | 523 Million DKK | -4.91% |
| 2022 Q1 | 356 Million DKK | -1.93% |
| 2022 FY | 523 Million DKK | 44.08% |
| 2022 Q2 | 554 Million DKK | 55.62% |
| 2022 Q3 | 550 Million DKK | -0.72% |
| 2021 Q3 | 374 Million DKK | -2.6% |
| 2021 FY | 363 Million DKK | 31.05% |
| 2021 Q2 | 384 Million DKK | 17.79% |
| 2021 Q1 | 326 Million DKK | 17.69% |
| 2021 Q4 | 363 Million DKK | -2.94% |
| 2020 Q1 | 148 Million DKK | -4.52% |
| 2020 Q4 | 277 Million DKK | -6.1% |
| 2020 Q3 | 295 Million DKK | -5.75% |
| 2020 Q2 | 313 Million DKK | 111.49% |
| 2020 FY | 277 Million DKK | 78.71% |
| 2019 FY | 155 Million DKK | 0.0% |
| 2019 Q1 | 168.27 Million DKK | 0.0% |
| 2019 Q2 | 162.81 Million DKK | -3.25% |
| 2019 Q3 | 157.61 Million DKK | -3.19% |
| 2019 Q4 | 155 Million DKK | -1.66% |
| 2018 Q2 | - DKK | 0.0% |
| 2018 FY | - DKK | 0.0% |
| 2018 Q1 | - DKK | 0.0% |
| 2018 Q4 | - DKK | 0.0% |
| 2018 Q3 | - DKK | 0.0% |
| 2017 Q3 | - DKK | 0.0% |
| 2017 FY | - DKK | 0.0% |
| 2017 Q2 | - DKK | 0.0% |
| 2017 Q1 | - DKK | 0.0% |
| 2017 Q4 | - DKK | 0.0% |
| 2016 Q1 | - DKK | 0.0% |
| 2016 Q4 | - DKK | 0.0% |
| 2016 Q3 | - DKK | 0.0% |
| 2016 Q2 | - DKK | 0.0% |
| 2016 FY | - DKK | 0.0% |
| 2015 FY | - DKK | -100.0% |
| 2015 Q4 | - DKK | 0.0% |
| 2015 Q3 | - DKK | 0.0% |
| 2015 Q2 | - DKK | -100.0% |
| 2015 Q1 | 59 Thousand DKK | -50.0% |
| 2014 Q3 | 178 Thousand DKK | -24.89% |
| 2014 Q4 | 118 Thousand DKK | -33.71% |
| 2014 FY | 118 Thousand DKK | -66.85% |
| 2014 Q1 | 297 Thousand DKK | -16.57% |
| 2014 Q2 | 237 Thousand DKK | -20.2% |
| 2013 Q1 | 925 Thousand DKK | -51.11% |
| 2013 FY | 356 Thousand DKK | -81.18% |
| 2013 Q4 | 356 Thousand DKK | -14.22% |
| 2013 Q3 | 415 Thousand DKK | -12.63% |
| 2013 Q2 | 475 Thousand DKK | -48.65% |
| 2012 Q1 | 4.73 Million DKK | -21.86% |
| 2012 FY | 1.89 Million DKK | -68.76% |
| 2012 Q3 | 2.84 Million DKK | -24.95% |
| 2012 Q4 | 1.89 Million DKK | -33.57% |
| 2012 Q2 | 3.79 Million DKK | -19.8% |
| 2011 Q1 | 10.3 Million DKK | -12.99% |
| 2011 Q2 | 8.7 Million DKK | -15.54% |
| 2011 Q3 | 5.99 Million DKK | -31.13% |
| 2011 FY | 6.05 Million DKK | -48.88% |
| 2011 Q4 | 6.05 Million DKK | 1.02% |
| 2010 Q1 | 16.4 Million DKK | -8.55% |
| 2010 Q4 | 11.84 Million DKK | -11.48% |
| 2010 FY | 11.84 Million DKK | -33.96% |
| 2010 Q3 | 13.38 Million DKK | -10.2% |
| 2010 Q2 | 14.9 Million DKK | -9.16% |
| 2009 FY | 17.93 Million DKK | 100.11% |
| 2009 Q4 | 17.93 Million DKK | 0.0% |
| 2008 FY | 8.96 Million DKK | 9.56% |
| 2007 FY | 8.18 Million DKK | -27.28% |
| 2006 FY | 11.25 Million DKK | -22.33% |
| 2005 FY | 14.48 Million DKK | -30.89% |
| 2004 FY | 20.96 Million DKK | 12.88% |
| 2003 FY | 18.56 Million DKK | 74.76% |
| 2002 FY | 10.62 Million DKK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1928.942% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -60344.444% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -3090809.091% |
| Autolus Therapeutics plc | 47.91 Million USD | -1319.209% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -99025.364% |
| Shattuck Labs, Inc. | 3.4 Million USD | -19864.768% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2945.776% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -20896.526% |
| Aptose Biosciences Inc. | 621 Thousand USD | -109400.805% |
| Precision BioSciences, Inc. | 7.72 Million USD | -8704.869% |
| Dyadic International, Inc. | 88.87 Thousand USD | -765062.597% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2446.816% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -492653.623% |
| Nektar Therapeutics | 112.62 Million USD | -503.774% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -7145.605% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -686768.687% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -13760.579% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -420.435% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -8289.883% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -931406.849% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1861.237% |
| INmune Bio, Inc. | 397 Thousand USD | -171184.635% |
| Opthea Limited | 200.53 Million USD | -239.092% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1266.23% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -4468.357% |
| Verastem, Inc. | 40.08 Million USD | -1596.353% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -15347.524% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -6663.477% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -10264.274% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -11715.812% |
| NextCure, Inc. | 5.94 Million USD | -11330.493% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -754416.0% |
| Organovo Holdings, Inc. | 888 Thousand USD | -76476.577% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 800 Thousand USD | -84900.0% |
| Ovid Therapeutics Inc. | 30 Million USD | -2166.667% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3498.836% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2677.324% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -798.283% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2524.773% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1867.82% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1927.551% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -254581.648% |
| PureTech Health plc | 18.25 Million USD | -3626.027% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -468865.517% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -5976.311% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -768.133% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 2.57 Million USD | -26307.767% |
| Beam Therapeutics Inc. | 159.91 Million USD | -325.237% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -855.11% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -2840.541% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -630.923% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 40.14 Million USD | -1593.902% |
| Mesoblast Limited | 100.48 Million USD | -576.731% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -256.148% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -598.439% |
| MediWound Ltd. | 6.35 Million USD | -10608.661% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -575.958% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1017.392% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -98.551% |
| Achilles Therapeutics plc | 1.07 Million USD | -63097.026% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -569.66% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -8350.354% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1095.205% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -9605.966% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -2180.425% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -5.448% |
| FibroGen, Inc. | 89.69 Million USD | -658.108% |
| Celcuity Inc. | 37.03 Million USD | -1736.081% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -15579.041% |
| ContextLogic Inc. | 6 Million USD | -11233.333% |
| GH Research PLC | 631 Thousand USD | -107665.452% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -17790.029% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1837737.838% |
| ImmuCell Corporation | 10.54 Million USD | -6351.309% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -34243.434% |
| Amarin Corporation plc | 8.73 Million USD | -7682.992% |
| TG Therapeutics, Inc. | 100.11 Million USD | -579.199% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -12499.592% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -37386.218% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1760.211% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -131428.046% |
| Aptorum Group Limited | 3.05 Million USD | -22133.121% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -2124.112% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 16.18% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -215089.873% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -550.046% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1775774.226% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -15153.477% |
| Ardelyx, Inc. | 51.54 Million USD | -1219.184% |
| Ainos, Inc. | 5.92 Million USD | -11383.468% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -3070.607% |
| Prothena Corporation plc | 10.72 Million USD | -6242.692% |
| HilleVax, Inc. | 25.24 Million USD | -2593.709% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -3325.52% |
| Celularity Inc. | 26.17 Million USD | -2497.7% |
| Rallybio Corporation | 173 Thousand USD | -392963.584% |
| Cue Biopharma, Inc. | 4.2 Million USD | -16082.77% |
| Omeros Corporation | 329.7 Million USD | -106.245% |
| Humacyte, Inc. | 38.6 Million USD | -1661.658% |
| Immunocore Holdings plc | 82.64 Million USD | -722.806% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -42057.471% |
| Blueprint Medicines Corporation | 610.96 Million USD | -11.3% |
| IO Biotech, Inc. | 1.83 Million USD | -36876.618% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -46539.232% |
| Summit Therapeutics Inc. | 103.29 Million USD | -558.341% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -614.368% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1296.763% |
| Pulmatrix, Inc. | 8.32 Million USD | -8066.206% |
| Elicio Therapeutics, Inc. | 6 Million USD | -11220.127% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1146.106% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -5152.993% |
| Acelyrin, Inc. | 1.19 Million USD | -56851.424% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -602.864% |
| Cytokinetics, Incorporated | 607.37 Million USD | -11.958% |
| Vor Biopharma Inc. | 31.83 Million USD | -2036.349% |
| Evogene Ltd. | 10.65 Million USD | -6283.178% |
| Replimune Group, Inc. | 71.99 Million USD | -844.576% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -89491.568% |
| PDS Biotechnology Corporation | 19.5 Million USD | -3386.074% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2582897.797% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 60.823% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 6.62 Million USD | -10159.505% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -847.854% |
| Atai Life Sciences N.V. | 15.21 Million USD | -4370.449% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -266566.667% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -43212.102% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1475.898% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -165487.104% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -49571.293% |
| MiMedx Group, Inc. | 48.09 Million USD | -1313.751% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -102448.79% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -281.872% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -139.257% |
| Mereo BioPharma Group plc | 5.3 Million USD | -12730.189% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -115546.259% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2896.255% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 38.21 Million USD | -1679.406% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1652.081% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -7780.403% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Precigen, Inc. | 5.89 Million USD | -11435.199% |
| XOMA Corporation | 118.51 Million USD | -473.753% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -6653.402% |
| Incyte Corporation | 29.16 Million USD | -2231.802% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1733.922% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -8508.685% |
| Seer, Inc. | 25.96 Million USD | -2519.011% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | -204.923% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2623.922% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -4533233.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -244337.255% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | -304.723% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -499264.779% |
| UroGen Pharma Ltd. | 98.55 Million USD | -589.998% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -356.027% |
| Entera Bio Ltd. | 256 Thousand USD | -265525.0% |
| Lisata Therapeutics, Inc. | 137.00 USD | -496350264.964% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -14146.805% |
| Chimerix, Inc. | 125 Thousand USD | -543900.0% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -105819.003% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -391.671% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 86.688% |
| AnaptysBio, Inc. | 16.03 Million USD | -4140.195% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -9714185.714% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -47485.724% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -5368.876% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -1016266.49% |
| AbCellera Biologics Inc. | 71.22 Million USD | -854.761% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -36597.248% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -17274.969% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1596.607% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -743.934% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1210.49% |
| bluebird bio, Inc. | 224.41 Million USD | -203.005% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -14.653% |
| DBV Technologies S.A. | 4.52 Million USD | -14924.304% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1017.392% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -10844.793% |
| CorMedix Inc. | 517.01 Thousand USD | -131424.739% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -80.246% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -17941.921% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -65410.597% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -39503.96% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -73175.862% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -7636.944% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -3793.055% |
| Onconetix, Inc. | 118.85 Thousand USD | -572016.072% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -15507.069% |
| Adagene Inc. | 13.54 Million USD | -4922.144% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -228.553% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -1017193.998% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -31.095% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -950.761% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -3878.237% |
| SciSparc Ltd. | 24 Thousand USD | -2833233.333% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -729.098% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -17677.778% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4604.301% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -236.969% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 70.978% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2956421.739% |
| 2seventy bio, Inc. | 244.01 Million USD | -178.674% |
| ADMA Biologics, Inc. | 130.59 Million USD | -420.698% |
| Clene Inc. | 7.15 Million USD | -9407.83% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -20040.635% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -174.618% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -61662.035% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -258587.92% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -253.027% |
| Absci Corporation | 4.66 Million USD | -14492.275% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 74.842% |
| Surrozen, Inc. | 882 Thousand USD | -76997.506% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2524.672% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -2853.312% |
| Cingulate Inc. | 135.09 Thousand USD | -503234.592% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -2094.044% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1322.594% |
| Kronos Bio, Inc. | 25.37 Million USD | -2579.381% |
| Innoviva, Inc. | 446.23 Million USD | -52.386% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -3799.753% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -1027.302% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -67164.53% |
| AlloVir, Inc. | 16.64 Million USD | -3984.575% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1357.414% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -9113959.778% |
| Kura Oncology, Inc. | 9.33 Million USD | -7186.755% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -9939.864% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -147726.087% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -291.36% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -16672.481% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -462645.578% |
| HCW Biologics Inc. | 6.3 Million USD | -10686.258% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -934.11% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1388.193% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -43.651% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1105662.976% |
| Histogen Inc. | 4.38 Million USD | -15410.949% |
| Surrozen, Inc. | 882 Thousand USD | -76997.506% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | -580.0% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -27100.109% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -730266.042% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -952.192% |
| Avalo Therapeutics, Inc. | 2 Million USD | -33900.0% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 51.442% |
| Turnstone Biologics Corp. | 1.18 Million USD | -57090.917% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -623753.211% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -729.177% |
| Exelixis, Inc. | 189.94 Million USD | -258.0% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1485.932% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2576.744% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | -136.333% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -37386.218% |
| Arcellx, Inc. | 50.84 Million USD | -1237.503% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -342.729% |
| Insmed Incorporated | 1.19 Billion USD | 43.018% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -46539.232% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -3101.808% |
| Moolec Science SA | 99.04 Thousand USD | -686449.684% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2361.895% |
| Geron Corporation | 35.05 Million USD | -1840.03% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -114959.222% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1486.043% |
| Royalty Pharma plc | 6.13 Billion USD | 88.917% |
| OmniAb, Inc. | 22.07 Million USD | -2980.408% |
| Alector, Inc. | 30.45 Million USD | -2132.729% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -41312.911% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -2837.619% |
| Humacyte, Inc. | 38.6 Million USD | -1661.658% |
| Structure Therapeutics Inc. | 4.01 Million USD | -16844.929% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -59.402% |
| 89bio, Inc. | 24.79 Million USD | -2642.488% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -3930.824% |
| Immunic, Inc. | 639 Thousand USD | -106316.275% |
| Veracyte, Inc. | 7.52 Million USD | -8936.545% |
| Genelux Corporation | 1.86 Million USD | -36341.586% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -65791.473% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -519527.397% |
| Immunovant, Inc. | - USD | -Infinity% |
| Vericel Corporation | 81.85 Million USD | -730.727% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 58.344% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -11205.071% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -395.179% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1136605.56% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1403.228% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1417.789% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -499900.0% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -151329.787% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -10755.683% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -56284.743% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -138675.51% |
| United Therapeutics Corporation | 300 Million USD | -126.667% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -309.38% |
| XOMA Corporation | 118.51 Million USD | -473.753% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | -478.094% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -12021.212% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -3283.253% |
| uniQure N.V. | 130.06 Million USD | -422.816% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -8251.756% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -452476.023% |
| Windtree Therapeutics, Inc. | 15 Million USD | -4433.333% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1060.608% |
| Pluri Inc. | 29.05 Million USD | -2240.55% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 72.11 Million USD | -842.886% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -18910.344% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -648.067% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -75.322% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -12021.212% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -144889.339% |
| Nutriband Inc. | 79.82 Thousand USD | -851752.78% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -15065.031% |
| Compugen Ltd. | 719 Thousand USD | -94475.8% |
| Roivant Sciences Ltd. | 477.85 Million USD | -42.302% |
| ProKidney Corp. | 3.61 Million USD | -18736.565% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -1038242.317% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1745.92% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -80622.801% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -13322.819% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 7.83 Million USD | -8584.547% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -31527.907% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -5801.753% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -6696.602% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -704.21% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -5810.474% |
| Imunon, Inc. | 1.13 Million USD | -59586.139% |
| BioAtla, Inc. | 836 Thousand USD | -81239.713% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -669.701% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -14340.433% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -4839.348% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -488.847% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -3265.504% |
| Galecto, Inc. | 66 Thousand USD | -1030203.03% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4604.301% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 54.644% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -583.362% |
| PolyPid Ltd. | 6.37 Million USD | -10559.978% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -643.901% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 14.64 Million USD | -4544.174% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -453233.333% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -499264.779% |
| Instil Bio, Inc. | 81.42 Million USD | -735.104% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -102448.79% |
| OncoCyte Corporation | 2.2 Million USD | -30752.995% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2156.363% |
| Purple Biotech Ltd. | 163 Thousand USD | -417077.914% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -26724.458% |
| MacroGenics, Inc. | 30.19 Million USD | -2151.954% |
| Verona Pharma plc | 48.37 Million USD | -1305.714% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -72783.173% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -7278.472% |
| Aditxt, Inc. | 1.04 Million USD | -65175.154% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2480.841% |
| Curis, Inc. | 1.48 Million USD | -45568.234% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -97360.998% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -11333233.333% |
| BeiGene, Ltd. | 197.61 Million USD | -244.098% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -50646.269% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -799900.0% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -17951.5% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1191.352% |
| Adicet Bio, Inc. | 17.7 Million USD | -3741.157% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4850.135% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | -657.458% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2965.134% |
| Invivyd, Inc. | 722 Thousand USD | -94082.825% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1302.004% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -23257861.576% |
| Moolec Science SA | 99.04 Thousand USD | -686449.684% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1519.51% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -6954.674% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -508.921% |
| Evaxion Biotech A/S | 8.48 Million USD | -7910.603% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -807.574% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -10839.511% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2788.823% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -377677.778% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -81532.653% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -21229.987% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -72549.573% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -4959.9% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1329.923% |
| ImmunityBio, Inc. | 836.95 Million USD | 18.753% |
| Korro Bio, Inc. | 31.21 Million USD | -2078.37% |
| Kineta, Inc. | 150 Thousand USD | -453233.333% |
| BioVie Inc. | 349.89 Thousand USD | -194244.573% |
| Codexis, Inc. | 12.24 Million USD | -5454.194% |
| Celularity Inc. | 26.17 Million USD | -2497.7% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -385507.758% |
| Cibus, Inc. | 17.67 Million USD | -3747.46% |
| Annexon, Inc. | 29.19 Million USD | -2229.565% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -60506.061% |
| Eyenovia, Inc. | 8.95 Million USD | -7491.632% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -935.654% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2511813.117% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -64354.976% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -126765.672% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -2142172.069% |
| Notable Labs, Ltd. | 1.52 Million USD | -44460.944% |
| IN8bio, Inc. | 3.37 Million USD | -20024.297% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -214411.041% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1263.354% |
| Lumos Pharma, Inc. | 6 Million USD | -11233.333% |
| Liquidia Corporation | 2.36 Million USD | -28664.805% |
| Mustang Bio, Inc. | 1.97 Million USD | -34278.16% |
| Quantum-Si incorporated | 13.73 Million USD | -4850.135% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -9679.951% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -7278.472% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1837737.838% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -3410814.928% |
| Vaxcyte, Inc. | 22.11 Million USD | -2975.392% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -6980.383% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -6747.936% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -3961.537% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -522976.923% |
| PepGen Inc. | 17.1 Million USD | -3876.608% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -143359.916% |
| Solid Biosciences Inc. | 23.94 Million USD | -2740.316% |
| Palisade Bio, Inc. | 90 Thousand USD | -755455.556% |
| Nutriband Inc. | 79.82 Thousand USD | -851752.78% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -16234.955% |
| Belite Bio, Inc | 578 Thousand USD | -117547.059% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -5230669.231% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -350415.464% |
| Altimmune, Inc. | 175 Thousand USD | -388471.429% |
| Peak Bio, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -15579.041% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -48997.473% |
| Neurogene Inc. | 13.37 Million USD | -4984.873% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -121.917% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2489.194% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -4328.813% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -6747.936% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -404661.905% |
| Immunome, Inc. | 1.34 Million USD | -50646.269% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -29034.533% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -67900.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1578.681% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -6063.85% |
| Athira Pharma, Inc. | 1.21 Million USD | -55775.103% |
| XOMA Corporation | 118.51 Million USD | -473.753% |
| Merus N.V. | 10.48 Million USD | -6383.6% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -4963.668% |
| Rezolute, Inc. | 1.66 Million USD | -40863.855% |
| Clene Inc. | 7.15 Million USD | -9407.83% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -926987.31% |
| BeyondSpring Inc. | 3.36 Million USD | -20114.031% |
| Synlogic, Inc. | 12.49 Million USD | -5343.92% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1982.313% |
| Krystal Biotech, Inc. | 6.62 Million USD | -10171.903% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -297.849% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -11240.894% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1435377.402% |
| MannKind Corporation | 252.15 Million USD | -169.68% |
| Ikena Oncology, Inc. | 7.18 Million USD | -9370.752% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -341608.543% |
| Gossamer Bio, Inc. | 197.4 Million USD | -244.469% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -130669.231% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -141.711% |
| Mural Oncology plc | 8.91 Million USD | -7531.018% |
| Disc Medicine, Inc. | 1.43 Million USD | -47253.76% |
| Champions Oncology, Inc. | 6.09 Million USD | -11060.348% |
| REGENXBIO Inc. | 82.22 Million USD | -727.029% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -137550.986% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -15236.04% |
| Vaxart, Inc. | 2.62 Million USD | -25824.514% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -250239.615% |
| Cellectis S.A. | 36.24 Million USD | -1776.328% |
| Longeveron Inc. | 1.44 Million USD | -46861.326% |
| Repare Therapeutics Inc. | 1.01 Million USD | -67226.733% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 39.957% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1418.908% |
| Revolution Medicines, Inc. | 80.57 Million USD | -743.934% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -21097.007% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -384080.791% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -552745.528% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 6.168% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1411.749% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -5338.151% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -503234.592% |
| Passage Bio, Inc. | 22.92 Million USD | -2866.712% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -11160.142% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -105000.464% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -3272.18% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -166788.776% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -57139.057% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -145822.747% |
| OmniAb, Inc. | 22.07 Million USD | -2980.408% |
| Anew Medical, Inc. | 1.54 Million USD | -44055.844% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -2200.407% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -7427.953% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -2087.198% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -16672.481% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1218.929% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -10580.069% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4712.796% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -101090.476% |
| Alumis Inc. Common Stock | 30.86 Million USD | -2103.5% |
| Equillium, Inc. | 384 Thousand USD | -176983.333% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -10940.753% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -22357.067% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -3438933.025% |
| vTv Therapeutics Inc. | 169 Thousand USD | -402266.864% |
| Bio-Techne Corporation | 319 Million USD | -113.166% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1093.234% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -280.812% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -4313.578% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -5391.399% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -14046.037% |
| Nkarta, Inc. | 82.27 Million USD | -726.547% |
| BioCardia, Inc. | 982 Thousand USD | -69146.436% |
| Iterum Therapeutics plc | 18.95 Million USD | -3487.255% |